Clinical Trial Update: Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine sulfate for efficacy and safety in patients with systemic lupus erythematosus or cutaneous lupus erythematosus with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

Sponsor: Sanofi | Conditions: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED